Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Infections and immune factors in cancer: the role of epidemiology

Oncogene volume 23, pages 6341–6348 (2004)Cite this article

Abstract

An infective, mostly viral, basis has been found in an increasing number of different human cancers. In all cases, the neoplasm is a rare response to the relevant infection, which is usually present in persistent form, and requiring specific cofactors for malignancy to develop. In some cases, epidemiological evidence of infectivity preceded and promoted identification of the specific infection involved and even the discovery of the microbe itself, as in Burkitt's lymphoma and cervix cancer. In other cases, the discovery of the agent came first as in stomach and nasopharynx cancers, and epidemiology has been concerned mainly with confirming the relationship, measuring the size of the risk and identifying cofactors. Infection-linked cancers include some of the commonest malignancies in certain large world regions, amounting to over 20% of all cancer in the developing countries. In addition to these cancers are others such as childhood leukaemia that show features indicative of an infective basis though no underlying agent has been identified. Advances in this field invite speculation about possible future discoveries and how these might be promoted. However, in that majority of cancers that are unrelated to sexual behaviour, there will be nothing even at the population level to suggest an infective basis because what is transmitted from one individual to another is not the neoplasm itself, but the underlying, often silent, infection to which the malignancy is an uncommon response. The increasing prevalence of immune impairment in human populations, as a result of the use of immunosuppressive drugs with organ transplants and the spread of HIV infection, has produced marked effects on cancer incidence in the affected groups including increases, of skin cancers, non-Hodgkin's lymphoma and Kaposi's sarcoma and to a lesser extent of many other cancers, in some cases at least due to the release from immunological control of incipient infection-based malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Adami J, Gabel H, Lindelof, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami H-O and Granath F . (2003). Br. J. Cancer, 89, 1221–1227.

  • Alexander FE, Boyle P, Carli PM, Coebergh JW, Ekbom A, Levi F, McKinney PA, McWhirter W, Michaelis J, Peris-Bonet R, Petridou E, Pompe-Kirn V, Plesko I, Pukkala E, Rahu M, Stiller CA, Storm H, Terracini B, Vatten L and Wray N . (1999). Eur. J. Cancer, 35, 439–444.

  • Alexander FE, Chan LC, Lam TH, Yuen P, Leung NK, Ha SY, Yuen HL, Li CK, Li CK, Lau YL and Greaves MF . (1997). Br. J. Cancer, 75, 457–763.

  • Beasley RP and Hwang L-Y . (1991). Viral Hepatitis and Liver Disease. Hollonger FB, Lemon SM and Margolis HS (eds). Williams and Wilkins: Baltimore, pp. 532–535.

    Google Scholar 

  • Beasley RP, Hwang L-Y, Lin CC and Chien CS . (1981). Lancet, 2, 1129–1133.

  • Beral V, Peterman TA, Berkelman R and Jaffe H . (1990). Lancet, 335, 123–128.

  • Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L, Glattre E, Halvorsen S, Holm NV, Jakobsen A, Jorgensen HE, Ladefoged J, Lindholm T, Lundgren G and Pukkala E . (1995). Int. J. Cancer, 60, 183–189.

  • Boschoff C and Weiss R . (2002). Nat. Rev.: Cancer, 2, 373–382.

  • Boutou O, Guizard AV, Slama R, Pottier D and Spira A . (2002). Br. J. Cancer, 87, 740–745.

  • Burkitt D . (1962). Nature, 194, 232–234.

  • Burnet FM . (1970). Prog. Exp. Tumor Res., 13, 1–27.

  • Castellsague X and Munoz N . (2003). J. Natl. Cancer Inst. Monogr., 31, 20–28.

  • Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS . (1994). Science, 266, 1865–1869.

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW and Houghton M . (1989). Science, 244, 359–362.

  • Crawford DH, Edwards JMB, Sweny P, Hoffbrand AV and Janossy G . (1981). Int. J. Cancer, 28, 705–709.

  • Danesh J . (1999). Infections and Human Cancer: Cancer Surveys, 33. CSHL Press: New York.

    Google Scholar 

  • Demeter LM, Stoler MH, Bonnez W, Corey L, Pappas P, Strussenberg J and Reichman RC . (1993). J. Infect. Dis., 168, 38–46.

  • Dickinson HO and Parker L . (1999). Br. J. Cancer, 81, 144–151.

  • Dockerty JD, Draper G, Vincent T, Rowan SD and Bunch KJ . (2001). Int. J. Epidemiol., 30, 1428–1437.

  • Doll R . (1999). Br. J. Cancer, 81, 3–5.

  • Donato F, Boffetta P and Puoti M . (1998). Int. J. Cancer, 75, 347–354.

  • Durst M, Gissmann L, Ikenberg H and zur Hausen H . (1983). Proc. Natl. Acad. Sci. USA, 80, 3812–3815.

  • Epstein MA, Achong BA and Barr YM . (1964). Lancet, 1, 702–703.

  • Franceschi S, Munoz N and Snijders PJ . (2000). Lancet, 356, 871–872.

  • Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D . (2000). J. Natl. Cancer Inst., 92, 709–720.

  • Greaves MF . (1988). Leukaemia, 7, 349–360.

  • Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL and Najarion JS . (1981). Cancer Res., 41, 4253–4261.

  • Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Svidhar H, Rose G, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJF, Meijer CJLM, Viscidi R, Munoz N and Franceschi S . (2003). J. Natl. Cancer Inst., 95, 1772–1783.

  • Herrington MM, Weiss NS and Olshan AF . (1996). Cancer epidemiology and Prevention. Scottenfeld D, Fraumeni JR (eds). Oxford University Press: New York, Oxford and Tokyo.

    Google Scholar 

  • Hoover R and Fraumeni JF . (1973). Lancet, 2, 5–7.

  • Infante-Rivard C, Fortier I and Olsen E . (2000). Br. J. Cancer, 83, 1559–1564.

  • International Agency for Research on Cancer (IARC) (1994a). Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol 59. IARC: Lyon.

  • International Agency for Research on Cancer (IARC) (1994b). Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol 61. IARC: Lyon.

  • International Agency for Research on Cancer (IARC) (1995). IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol 64. IARC: Lyon.

  • Jourdan-Da Silva N, Perel Y, Mechinaud F, Plouvier E, Gandemer V, Lutz P, Vannier JP, Lamagnere JL, Margueritte G, Boutard P, Robert A, Armari C, Munzer M, Millot F, Lumley L de, Berthou C, Rialland Y, Pautard B, Hemon D and Clavel J . (2004). Br. J. Cancer, 90, 139–145.

  • Kinlen L . (1988). Lancet, 2, 1323–1327.

  • Kinlen L and Doll R . (2004). Br. J. Cancer, 91, (in press).

  • Kinlen LJ . (1995). Br. J. Cancer, 71, 1–5.

  • Kinlen LJ . (2000). Radiol. Prot. Bull., 226, 9–18.

  • Kinlen LJ and Balkwill A . (2001). Lancet, 357, 858.

  • Kinlen LJ and Balkwill A . In preparation.

  • Kinlen LJ, Clarke K and Hudson C . (1990). Lancet, 336, 577–582.

  • Kinlen LJ, Dickson M and Stiller CA . (1995). BMJ, 310, 763–768.

  • Kinlen LJ and Hudson C . (1991). BMJ, 303, 1357–1362.

  • Kinlen LJ and John SM . (1994). BMJ, 309, 1197–1202.

  • Kinlen LJ, O'Brien F, Clarke K, Balkwill A and Matthews F . (1993). BMJ, 306, 743–748.

  • Kinlen LJ and Petridou E . (1995). Cancer Causes Control, 6, 445–450.

  • Kinlen LJ and Pike MC . (1971). Lancet, 2, 398–402.

  • Kinlen LJ, Sheil AGR, Peto J and Doll R . (1979). BMJ, 2, 1461–1466.

  • Koushik A, King WD and McLaughlin JR . (2001). Cancer Causes Control, 12, 483–490.

  • Labrecque LG, Barnes DM, Fentiman IS and Griffin BE . (1995). Cancer Res., 55, 39–45.

  • Lin CT, Lin CR, Tan GK, Chen W, Dee AN and Chan WY . (1997). Am. J. Pathol., 150, 1745–1756.

  • Little J and Epidemiology of Childhood Cancer. (1999). Epidemiology of childhood cancer IARC Scientific Publications, Vol 149. International Agency for Research on Cancer: Lyon.

    Google Scholar 

  • Ma X, Buffler PA, Selvin S, Mattay KK, Wiencke JK, Wiemels JL and Reynolds P . (2002). Br. J. Cancer, 86, 1419–1424.

  • MacMahon B . (1966). Cancer Res., 26, 1189–1200.

  • Magrath I and Bhatia K . (1999). J. Natl. Cancer Inst., 91, 1349–1350.

  • Newton R . (1996). Br. J. Cancer, 74, 1511–1513.

  • Newton R, Beral V and Weiss R . (1999a). Infections and Human Cancer. Cancer Surveys, Vol 33. CSHL Press: New York, pp. 237–262.

    Google Scholar 

  • Newton R, Wu W and Anwar W . (1999b). Infections and Human Cancer. Cancer Surveys, Vol 33. CSHL Press: New York, pp. 291–311.

    Google Scholar 

  • Old LJ, Boyse EA and Oettgen HF . (1966). Proc. Natl. Acad. Sci. USA, 56, 1699–1704.

  • Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M and Rzesa G . (1978). Proc. Natl. Acad. Sci. USA, 75, 1537–1541.

  • Parkin DM, Pisani P, Munoz N and Ferlay J . (1999). Infections and Human Cancer Cancer Surveys Vol 33. CSHL Press: New York.

    Google Scholar 

  • Petridou E, Kassimos D, Kalmanti M, Kosmidis H, Haidas S, Flytzani V, Tong D and Trichopoulos D . (1993). BMJ, 307, 774.

  • Petridou E, Revinthi K, Alexander FE, Haidas S, Koliouskas D, Kosmidis H, Piperopoulou F, Tzortzatou F and Trichopoulos D . (1996). Br. J. Cancer, 73, 1278–1283.

  • Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC . (1980). Proc. Nat. Acad. Sci. USA, 77, 7415–7419.

  • Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN and Groopman JD . (1994). Cancer Epidemiol. Biomark. Prev., 3, 3–10.

  • Rigoni-Stern DA . (1842). G. serv. progr. patol. terapeut. Serie II, tomo II, 507–517.

  • Rosenbaum PF, Buck GM and Brecher ML . (2000). Am. J. Epidemiol., 152, 1136–1144.

  • Ross RK, Yuan J-M, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT and Henderson BE . (1992). Lancet, 339, 943–946.

  • Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ and Schreiber RD . (2001). Nature, 410, 1107–1111.

  • Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP and Haugen TH . (1998). Laryngoscope, 108, 1098–1103.

  • Steenbergen RD, Hermsen MA, Walboomers JM, Joenje H, Arwert F and Meijer CJ . (1995). Cancer Res., 55, 5465–5471.

  • Thomas L . (1959). Cellular and Humoral Aspects of Hypersensitivity States. Lawrence HS (ed). Cassell: London, pp 529–532.

    Google Scholar 

  • Uchiyama T, Yodoi J, Sagawa K, Takatsudi K and Uchino H . (1977). Blood, 50, 481–492.

  • Vizcaino AP, Parkin DM, Bofetta P and Skinner MEG . (1994). Cancer Causes Control, 5, 517–522.

  • Vonka V, Kanka J, Hirsh I, Zavadova H, Krcmar M, Suchankova A, Rezacova D, Broucek J, Press M, Domorazkova E, Svoboda B, Havrankova A and Jelinek J . (1984). Int. J. Cancer, 33, 61–66.

  • Warren JR and Marshall BJ . (1983). Lancet, 1, 1273.

  • Wild CP, Rasheed FN, Jawla MF, Hall AJ, Jansen LA and Montesano R . (1991). Lancet, 337, 1602.

  • Xue SA, Lampert IA, Haldane JS, Bridger JE and Griffin BE . (2003). Br. J. Cancer, 89, 113–119.

  • Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M and Daling J . (2001). Cancer Epidemiol. Biomark. Prev., 10, 9–16.

  • Yu MW and Chen CJ . (1993). Cancer Res., 53, 790–794.

Download references

Author information

Authors and Affiliations

  1. Cancer Epidemiology Unit, Gibson Building, Radcliffe Infirmary, Oxford, OX2 6HE, UK

    Leo Kinlen

Authors
  1. Leo Kinlen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leo Kinlen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinlen, L. Infections and immune factors in cancer: the role of epidemiology. Oncogene 23, 6341–6348 (2004). https://doi.org/10.1038/sj.onc.1207898

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207898

Keywords

This article is cited by

Search

Advanced search

Quick links